Ladenburg Thalmann Financial Services’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-33
Closed -$1K 5245
2017
Q4
$1K Hold
33
﹤0.01% 4960
2017
Q3
$1K Hold
33
﹤0.01% 4858
2017
Q2
$1K Hold
33
﹤0.01% 4795
2017
Q1
$1K Hold
33
﹤0.01% 4769
2016
Q4
$1K Hold
33
﹤0.01% 4739
2016
Q3
$0 Hold
33
﹤0.01% 4909
2016
Q2
$0 Hold
33
﹤0.01% 4874
2016
Q1
$0 Hold
33
﹤0.01% 4844
2015
Q4
$0 Hold
33
﹤0.01% 4822
2015
Q3
$0 Hold
33
﹤0.01% 4773
2015
Q2
$1K Hold
33
﹤0.01% 4559
2015
Q1
$1K Hold
33
﹤0.01% 4479
2014
Q4
$1K Sell
33
-267
-89% -$11.7K ﹤0.01% 4265
2014
Q3
$15K Sell
300
-267
-47% -$15.3K ﹤0.01% 2868
2014
Q2
$37K Hold
567
﹤0.01% 2240
2014
Q1
$46K Buy
567
+534
+1,618% +$48.6K ﹤0.01% 2041
2013
Q4
$2K Hold
33
﹤0.01% 3533
2013
Q3
$3K Hold
33
﹤0.01% 3373
2013
Q2
$4K Buy
+33
New +$3.43K ﹤0.01% 3162

Other funds holding ALBO

Ladenburg Thalmann Financial Services's ALBO Position: Q1 2018 in Review

Ladenburg Thalmann Financial Services sold out of Albireo Pharma Inc (ALBO) in Q1 2018, closing a stake of 33 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in ALBO in Q2 2013 and held it in 19 quarters. The position peaked at $46K in Q1 2014. 50 funds tracked by Wall St. Rank hold ALBO as of Q1 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Albireo Pharma Inc position as of Q1 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 33 Albireo Pharma Inc shares in Q1 2018, an estimated $1K.
  • Ladenburg Thalmann Financial Services first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 19 quarters.
  • Ladenburg Thalmann Financial Services's Albireo Pharma Inc position peaked at $46K in Q1 2014.
  • 50 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2018, filed 15 May 2018.